MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,465 | -89.9% | 1,292 | -88.7% | 0.00% | -90.0% |
| Q2 2023 | $300,425 | +834413.9% | 11,410 | +479.8% | 0.01% | +900.0% |
| Q1 2023 | $36 | +33.3% | 1,968 | +14.3% | 0.00% | 0.0% |
| Q4 2022 | $27 | -100.0% | 1,722 | -63.3% | 0.00% | -50.0% |
| Q3 2022 | $94,000 | +276.0% | 4,697 | +330.5% | 0.00% | +100.0% |
| Q2 2022 | $25,000 | -71.6% | 1,091 | -67.3% | 0.00% | 0.0% |
| Q1 2022 | $88,000 | +363.2% | 3,341 | +462.5% | 0.00% | – |
| Q4 2021 | $19,000 | -55.8% | 594 | -69.8% | 0.00% | -100.0% |
| Q3 2021 | $43,000 | +87.0% | 1,968 | +48.2% | 0.00% | 0.0% |
| Q4 2020 | $23,000 | +283.3% | 1,328 | +232.8% | 0.00% | – |
| Q2 2020 | $6,000 | -72.7% | 399 | -78.5% | 0.00% | -100.0% |
| Q1 2020 | $22,000 | -24.1% | 1,855 | -9.5% | 0.00% | -50.0% |
| Q4 2019 | $29,000 | -39.6% | 2,049 | -23.9% | 0.00% | -33.3% |
| Q3 2019 | $48,000 | +1500.0% | 2,692 | +1169.8% | 0.00% | – |
| Q2 2017 | $3,000 | -40.0% | 212 | -68.8% | 0.00% | – |
| Q2 2016 | $5,000 | – | 679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |